about
Using single nucleotide polymorphisms as a means to understanding the pathophysiology of asthmaEthical perspectives on pharmacogenomic profiling in the drug development process.Pharmacogenomics for the treatment of dementia.Novel technology and the development of pharmacogenetics within the pharmaceutical industry.Beyond best practices: strict scrutiny as a regulatory model for race-specific medicines.Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pharmacogenomics: the genomics of drug response.
@ast
Pharmacogenomics: the genomics of drug response.
@en
type
label
Pharmacogenomics: the genomics of drug response.
@ast
Pharmacogenomics: the genomics of drug response.
@en
prefLabel
Pharmacogenomics: the genomics of drug response.
@ast
Pharmacogenomics: the genomics of drug response.
@en
P2860
P921
P1433
P1476
Pharmacogenomics: the genomics of drug response.
@en
P2093
P2860
P356
10.1002/(SICI)1097-0061(200004)17:1<16::AID-YEA6>3.0.CO;2-E
P577
2000-04-01T00:00:00Z